Skip to main content
Log in

Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone —a report of The International Study of Kidney Disease in Children

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

It has been claimed that long-term prednisone treatment ameliorates the course of children with mesangiocapillary glomerulonephritis (MCGN). The International Study of Kidney Disease in Children conducted a randomized, double-blinded, placebo-controlled clinical trial in 80 children with idiopathic MCGN, including 42 patients with type I disease, 14 with type II disease, 17 with type III disease, and 7 with nontypable disease. Criteria for admission included heavy proteinuria and a glomerular filtration rate of greater than or equal to 70 ml/min per 1.73 m2. Prednisone or lactose, 40 mg/m2, was given every other day as a single morning dose. The mean duration of treatment was 41 months, renal failure being the most common reason for termination of therapy. Treatment failure was defined as an increase from baseline of 30% or more in serum creatinine, or more than 35 μmol/l. Overall, treatment failure occurred in 55% of patients treated with lactose, compared with 40% in the prednisone group. Life-table analysis showed a renal survival rate (i.e., stable renal function) at 130 months of 61% among patients receiving prednisone and 12% among patients receiving lactose (P=0.07). Of patients with type I or III MCGN, 33% treated with prednisone were treatment failures, compared with 58% in the lactose group. Long-term treatment with prednisone appears to improve the outcome of children with MCGN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Habib R, Kleinknecht C, Gubler MC, Levy M (1973) Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol 1: 194–214

    Google Scholar 

  2. Ogg CS, Cameron JS, White RHR (1968) The C'3 component of complement in patients with heavy proteinuria. Lancet II: 78–81

    Google Scholar 

  3. International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13: 159–165

    Google Scholar 

  4. Cameron JS, Turner DR, Heaton J, Williams DG, Ogg CS, Chantler C, Haycock GB, Hicks J (1983) Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med 74: 175–192

    Google Scholar 

  5. Davis AE, Schneeberger EE, Grupe WE, McCluskey RT (1978) Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease in children (DDD). Clin Nephrol 9: 184–193

    Google Scholar 

  6. Habib R, Gubler MC, Loirat C, Maiz HB, Levy M (1975) Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int 7: 204–215

    Google Scholar 

  7. Strife CF, McEnery PT, McAdams AJ, West CD (1977) Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane. Clin Nephrol 7: 65–72

    Google Scholar 

  8. Galle P, Mahieu P (1975) Electron dense alteration of kidney basement membranes: a renal lesion specific of a systemic disease. Am J Med 58: 749–764

    Google Scholar 

  9. Lamb V, Tisher CC, McCoy RC, Robinson RR (1977) Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study. Lab Invest 36: 607–617

    Google Scholar 

  10. West DC (1981) Idiopathic membranoproliferative glomerulonephritis. In: Zurukzoglu W, Papadimitriou M, Pyrpasotoulos M, Sion M, Zamboulis C (eds) Proceedings of the 8th Congress of Nephrology (1981). Advances in basic and clinical nephrology. Karger, Athens, p 283

    Google Scholar 

  11. Donadio JV Jr, Anderson CF, Mitchell JC III, Holley KE, Ilstrup DM, Fuster V, Chesboro JH (1984) Membranoproliferative glomerulonephritis: a prospective clinical trial of platelet inhibitor therapy. N Engl J Med 310: 1421–1426

    Google Scholar 

  12. McEnery PT, McAdams AJ, West CD (1980) Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy. Clin Nephrol 13: 117–124

    Google Scholar 

  13. Kincaid-Smith P (1973) The natural history and treatment of mesangiocapillary glomerulonephritis. In: Kincaid-Smith P (ed) Glomerulonephritis, morphology, natural history and treatment. I. Wiley, New York, p 591

    Google Scholar 

  14. Chapman SJ, Cameron JS, Chantler C, Turner D (1980) Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation. Arch Dis Child 55: 446–451

    Google Scholar 

  15. Tiller DJ, Clarkson AR, Mathew T, Thompson N, Row G, Lauer C, Hobbs J, Seymour A (1981) A prospective randomized trial in the use of cyclophosphamide, dipyridamole, and warfarin in membranous and mesangiocapillary glomerulonephritis. In: Zurukzoglu W, Papadimitriou M, Pyrpasotoulos M, Sion M, Zamboulis C (eds) Proceedings of the 8th International Congress of Nephrology (1981). Advances in basic and clinical nephrology. Karger, Athens, p 345

    Google Scholar 

  16. McEnery PT, McAdams AJ, West CD (1985) The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis. Medicine (Baltimore) 64: 401–423

    Google Scholar 

  17. Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U (1983) Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis. Am J Med 75: 920–927

    Google Scholar 

  18. Warady BA, Guggenheim SJ, Sedman A, Lum GM (1985) Prednisone therapy of membranoproliferative glomerulonephritis in children. J Pediatr 107: 702–707

    Google Scholar 

  19. Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN (1985) Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 27: 436–441

    Google Scholar 

  20. Donadio JV, Offord KP (1989) Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on lifetable analysis. Am J Kidney Dis 14: 445–451

    Google Scholar 

  21. Churg J, Habib R, White RHR (1970) Pathology of the nephrotic syndrome in children. A report for the International Study of Kidney Disease in Children. Lancet I: 1299–1302

    Google Scholar 

  22. Churg J, Sobin LH (1982) Diffuse mesangiocapillary glomerulonephritis. In: Renal disease. Classification and atlas of glomerular diseases. Igaku-Shoin, Tokyo, p 83

    Google Scholar 

  23. SAS/STAT software: the PHREG procedure (preliminary edition documentation) (1991) SAS Institute, Cary, North Carolina

    Google Scholar 

  24. Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, London

    Google Scholar 

  25. Gross AJ, Clark VA (1975) Survival distributions: reliability applications in the biomedical sciences. Wiley, New York, p 45

    Google Scholar 

  26. Kalbfleisch JD, Prentice RL (1980) The Statistical analysis of failure time data. Wiley, New York

    Google Scholar 

  27. Jackson EX, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD (1987) Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation. Am J Kidney Dis 9: 115–120

    Google Scholar 

  28. White RHR (1992) Mesangiocapillary glomerulonephritis. In: Edelmann CM Jr, Bernstein J, Meadow SR, Spitzer A, Travis L (eds) Pediatric kidney disease, 2nd edn. Little Brown, Boston, pp 1307–1324

    Google Scholar 

  29. Donadio JV Jr, Offord KP (1989) Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on lifetable analysis. Am J Kidney Dis 6: 445–451

    Google Scholar 

  30. McEnery PT (1990) Membranoproliferative glomerulonephritis: the Cincinnati experience — cumulative renal survival from 1957 to 1989. J Pediatr 116: S110-S114

    Google Scholar 

  31. Strife CF, Jackson EC, McAdams AJ (1984) Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation. Clin Nephrol 21: 323–334

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarshish, P., Bernstein, J., Tobin, J.N. et al. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone —a report of The International Study of Kidney Disease in Children. Pediatr Nephrol 6, 123–130 (1992). https://doi.org/10.1007/BF00866289

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00866289

Key words

Navigation